期刊文献+

杀菌/通透性增加蛋白研究现状及应用前景 被引量:4

Research Progress and Application Prospect of Bactericidal/Permeability Increasing Protein
下载PDF
导出
摘要 杀菌/通透性增加蛋白(BPI)是中性粒细胞内存在的一种碱性蛋白,是一个分子质量介于50-60 ku的阳性蛋白,它主要存在于人、牛、兔等哺乳动物多形核粒细胞(PN4NL)的嗜天青颗粒中及其表面,它能与革兰氏阴性菌脂多糖(LPS)结合,具有中和内毒素和杀灭细菌的作用,在革兰氏阴性菌感染的治疗方面有良好的应用前景,人类最初注意杀菌性/通透性增加蛋白是因其具有杀菌作用,但随后发现它还具有较强的颉颃内毒素的作用。近年来国外对其研究颇多,并逐渐发现其还具有很多其他功能,如抗真菌、杀灭寄生虫等作用,其被学者称为未来的“超级抗生素”。 The bactericidal/permeability-increasing protein (BPI) is an antibiotic-and endotoxin-neutralizing protein in granulocytes and epithelial cells. It is a positive protein which molecular weight range between 50 and 60 ku. BPI is mainly found in azurophil granules and surface of PMN (PN4NL) from people, cattle, rabbits and other mammals. BPI can combine with the LPS and endotoxin of gram negative bacteria and produce effects of anti-endotoxin and kill bacterial. Therefore, it has a good future of application at prevention and cure of disease of Gram-negative bacterial. BPI initial found in the human protein because of its bactericidal effect and strong anti-endotoxin role. In recent research, it has been also found that it has many other functions, such as the effects of anti-fungal and killing parasites. Therefore it has been known as "super antibiotics" of the future.
出处 《中国畜牧兽医》 CAS 北大核心 2009年第9期29-34,共6页 China Animal Husbandry & Veterinary Medicine
基金 云南省自然科学基金(2005C0039M) 国家自然科学基金(30460055) 国家"863"项目
关键词 杀菌/通透性增加蛋白 内毒素 中性粒细胞 bactericidal/permeability-increasing protein endotoxin neutrophil
  • 相关文献

参考文献24

  • 1周红,郑江,秦孝建,肖光夏.抗人BPI抗体对猪源BPI体外生物活性的增强作用[J].第三军医大学学报,2002,24(1):76-78. 被引量:6
  • 2Abedin A,Mohammed I, Hopkinson A, et al. A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Invest Ophthalmol Vis Sci, 2008,19(1):28-33.
  • 3Abrahamaon S L,Wu H M,William R E,et al. Biochemical characterization of recombinant fusions of lipopolysaccharide binding protein and Bactericidal/permeability-increasing protein, implication in biological activity. J Biol Chein, 1997,272 ( 4 ) : 2149 -2155.
  • 4Aichele D,Schnare M, Saake M, et al. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients[J]. Infect Immun,2006,74(8) :4708-4714.
  • 5Anthony H C, Alistair P J. Meningococcal disease and its management in children[J]. BMJ, 2006,333 : 685- 690.
  • 6Beamer L J, Carroll S F, Eisenberg D. The three dimensiona structure of human bactericidal/ permeability increasing protein implications for understanding protein-lipopolysaccharide interactions[J]. Biochem Pharmacol, 1999,57:225 - 229.
  • 7Canny G O, McCormick B A. Bacteria in the intestine, helpful residents or enemies from within infect[J]. Immun,2008.76(8) : 3360-3373.
  • 8Canny G, Carlo E, et al. Functional and biochemical characterization of epithelial bactericidal/ permeability-increasing protein[J]. Am J Physiol Gastrointest Liver Physiol, 2006,290 ( 3 ) : G557- G567.
  • 9Cathie K, Levin M, Faust S N. Drug use in acute meningococcal disease. Arch Dis Child Ed Pract,2008,93: 151 -158.
  • 10Colin D B, Elizabeth E I.,et al. Phylogenetic and evolutionary analysis of the PLUNC gene family protein[J].Sci ,2004,13: 422.

二级参考文献8

  • 1[1]Dentener M A, mit F T, Francot G J. et al. Characterization of two monoclonal antibodies directed against bactericidal/permeability-increasing protein[J]. J Infect Dis,1994,170(6):1 483-1 489.
  • 2[2]Sandven P, Lassen J, Solberg O, et al. Comparative in vitro activity of tobramycin and gentamicin on three different media[J]. Chemotherapy,1980,26(5):354-360.
  • 3[3]Weiss J, Hutzler M, Kao L. Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophilbactericidal/ permeability-increasing protein[J]. Infect Immun,1986,51(2):594-599.
  • 4[4]Mannion B A, Weiss J,Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli[J]. J Clin Invest 1990,86(2):631-641.
  • 5[5]Weiss J. Purification and characterization of a potent bacteria and membranceactive protein from the granules of human polymorphonuclear leukocytes[J]. J BioChem,1978,253: 2 664-2 672.
  • 6[6]Elsbach P, Weiss J,Franson R C. et al. Separation and purification of apotent bactericidal/ permeability-increasing protein and a closely associatedphospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on theirrelationship[J]. J Biol Chem,1979,254(21):11 000-11 009.
  • 7[7]Spitznagel J K, Pereira H A, Martin L E ,et al.A monoclonal antibody thatinhibits the antimicrobial action of a 57 KD cationic protein of humanpolymorphonuclear leukocytes[J]. J Immunol,1987 Aug 15,139(4):1 291-1 296.
  • 8[8]Little R G. Functional domains of recombinant bactericidal/permeabilityincreasing protein (rBPI23)[J]. J Biol Chem,1994,269(3):1 865-1 872.

共引文献5

同被引文献64

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部